SEARCH

SEARCH BY CITATION

References

  • ADAMS, M.D., CHAIT, L.D. & EARNHARDT, J.T. (1976). Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat. Br. J. Pharmacol., 56, 4348.
  • BAUERSACHS, J., BOULOUMIE, A., FRACCAROLLO, D., HU, K., BUSSE, R. & ERTL, G. (1999). Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation, 100, 292298.
  • DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFF, C., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • FLETCHER, P.J., PFEFFER, J.M., PFEFFER, M.A. & BRAUNWALD, E. (1981). Left-ventricular diastolic pressure–volume relations in rats with healed myocardial infarction: effects on systolic function. Circ. Res., 49, 618626.
  • GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2002). Complex regional haemodynamic effects of anandamide in conscious rats. Br. J. Pharmacol., 135, 18891896.
  • GATLEY, S.J., GIFFORD, A.N., VOLKOW, N.D., LAN, R. & MAKRIYANNIS, A. (1996). 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol., 307, 331338.
  • GIULIANI, D., FERRARI, F. & OTTANI, A. (2000b). The cannabinoid agonist HU-210 modifies rat behavioural responses to novelty and stress. Pharmacol. Res., 41, 4753.
  • GIULIANI, D., OTTANI, A. & FERRARI, F. (2000a). Effects of the cannabinoid receptor agonist, HU-210, on ingestive behaviour and body weight of rats. Eur. J. Pharmacol., 391, 275279.
  • GRAINGER, J. & BOACHIE-ANSAH, G. (2001). Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br. J. Pharamacol., 134, 10031012.
  • HILLARD, C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther., 294, 2732.
  • HU, K., GAUDRON, P. & ERTL, G. (1998). Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left-ventricular remodeling in rats with experimental myocardial infarction. Importance of timing of treatment and infarct size. J. Am. Coll. Cardiol., 31, 692700.
  • JARAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 1413614141.
  • KLEIN, T.W., LANE, B., NEWTON, C.A. & FRIEDMAN, H. (2000). The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med., 225, 18.
  • KUNOS, G., JARAI, Z., BATKAI, S., GOPARAJU, S.K., ISHAC, E.J.N., LIU, J., WANG, L. & WAGNER, J.A. (2000). Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids, 108, 159168.
  • LAGNEUX, C. & LAMONTAGNE, D. (2001). Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br. J. Pharmacol., 132, 793796.
  • LAKE, K.D., COMPTON, D.R., VARGA, K., MARTIN, B.R. & KUNOS, G. (1997). Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 10301037.
  • LASER, M., WILLEY, C.D., JIANG, W., COOPER IV, G., MENOCK, D.R., ZILE, M.R. & KUPPUSWAMY, D. (2000). Integrin activation and focal complex formation in cardiac hypertrophy. J. Biol. Chem., 275, 3562435630.
  • LEDENT, C., VALVERDE, O., COSSU, G., PETITET, F., AUBERT, J.-F., BESLOT, F., BÖHME, G.A., IMPERATO, A., PEDRAZZINI, T., ROQUES, B.P., VASSART, G., FRATTA, W. & PARMENTIER, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401404.
  • MACCARONE, M., BARI, M., LORENZON, T., BISOGNO, T., DI MARZO, V. & FINAZZI-AGRO, A. (2000). Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 1348413492.
  • MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561564.
  • MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEL, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 8390.
  • MITTLEMAN, M.A., LEWIS, R.A., MACLURE, M., SHERWOOD, J.B. & MULLER, J.E. (2001). Triggering myocardial infarction by marijuana. Circulation, 103, 28052809.
  • PFEFFER, J.M., PFEFFER, M.A., BRAUNWALD, E. (1985). Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Cir. Res., 57, 8495.
  • STANEK, B., FREY, B., HULSMANN, M., BERGER, R., STURM, B., STRAMETZ-JURANEK, J., BERGLER-KLEIN, J., MOSER, P., BOJIC, A., HARTTER, E. & PACHER, R. (2001). Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left-ventricular dysfunction. J. Am. Coll. Cardiol., 38, 436442.
  • TSUTAMOTO, T., WADA, A., MAEDA, K., MABUCHI, N., HAYASHI, M., TSUTSUI, T., OHNISHI, M., SAWAKI, M., FUJII, M., MATSUMOTO, T., MATSUI, T. & KINOSHITA, M. (2001). Effect of spironolactone on plasma brain natriuretic peptide and left-ventricular remodeling in patients with congestive heart failure. J. Am. Coll. Cardiol., 37, 12281233.
  • VARGA, K., WAGNER, J.A., BRIDGEN, T.D. & KUNOS, G. (1998). Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J., 12, 10351044.
  • WAGNER, J.A., HU, K., BAUERSACHS, J., KARCHER, J., WIESLER, M., GOPARAJU, S.K., KUNOS, G. & ERTL, G. (2001a). Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol., 38, 20482054.
  • WAGNER, J.A., JARAI, Z., BATKAI, S. & KUNOS, G. (2001b). Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by CB1 receptors. Eur. J. Pharmacol., 423, 203210.
  • WAGNER, J.A., VARGA, K., ELLIS, E.F., RZIGALINSKI, B.A., MARTIN, B.R. & KUNOS, G. (1997). Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature, 390, 518521.
  • WAGNER, J.A., VARGA, K., JARAI, Z. & KUNOS, G. (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 33, 429434.
  • WHITE, R., HO, W.-S.V., BOTTRILL, F.E., FORD, W.R. & HILEY, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol., 134, 921929.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, J.A., CHUANG, H.-H., SORGARD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.